WFM
ABBV icon

Wilmington Funds Management’s AbbVie ABBV Stock Holding History

Wilmington Funds Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$2.64M Buy
46,709
+14,800
+46% +$776K 0.27% 107
2014
Q1 		$1.64M Hold
31,909
– – 0.18% 144
2013
Q4 		$1.69M Sell
31,909
-2,100
-6% -$103K 0.17% 159
2013
Q3 		$1.52M Buy
34,009
+2,800
+9% +$124K 0.15% 168
2013
Q2 		$1.29M Buy
+31,209
New +$1.36M 0.12% 183

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wilmington Funds Management's ABBV Position: Q2 2014 in Review

Wilmington Funds Management increased its AbbVie (ABBV) stake by 46% in Q2 2014, buying an estimated $776K and bringing the position to 46,709 shares worth $2.64M. The position accounts for 0.27% of the portfolio, ranked #107.

Wilmington Funds Management first reported a position in ABBV in Q2 2013 and has held it in 5 quarters since. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

  • Wilmington Funds Management held 46,709 shares of AbbVie worth $2.64M as of Q2 2014.
  • Wilmington Funds Management bought 14,800 AbbVie shares in Q2 2014, an estimated $776K.
  • AbbVie made up 0.27% of Wilmington Funds Management's portfolio in Q2 2014, its #107 holding.
  • Wilmington Funds Management first reported a position in AbbVie in Q2 2013 and has held it in 5 quarters since.
  • 1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.